OAKBX
Price
$36.20
Change
+$0.27 (+0.75%)
Updated
Dec 20 closing price
RLBAX
Price
$34.04
Change
+$0.26 (+0.77%)
Updated
Dec 20 closing price
Ad is loading...

OAKBX vs RLBAX

Header iconOAKBX vs RLBAX Comparison
Open Charts OAKBX vs RLBAXBanner chart's image
Oakmark Equity And Income Investor
Price$36.20
Change+$0.27 (+0.75%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R1
Price$34.04
Change+$0.26 (+0.77%)
VolumeN/A
CapitalizationN/A
OAKBX vs RLBAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
OAKBX vs. RLBAX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OAKBX is a Buy and RLBAX is a Buy.

FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 236B vs. OAKBX (6.64B). OAKBX pays higher dividends than RLBAX: OAKBX (2.69) vs RLBAX (1.59). OAKBX was incepted earlier than RLBAX: OAKBX (29 years) vs RLBAX (23 years). RLBAX is a more actively managed with annual turnover of: 171.00 vs. OAKBX (45.00). OAKBX has a lower initial minimum investment than RLBAX: OAKBX (0) vs RLBAX (250). OAKBX (9.40) and RLBAX (9.35) have marching annual gain over last year. OAKBX return over 5 years is better than : 31.07 vs. RLBAX (25.98).
OAKBXRLBAXOAKBX / RLBAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence29 years23 years-
Gain YTD8.9508.731103%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets6.64B236B3%
Annual Yield % from dividends2.691.59169%
Returns for 1 year9.409.35101%
Returns for 3 years12.427.62163%
Returns for 5 years31.0725.98120%
Returns for 10 years22.4745.3150%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRVL345.7211.47
+3.43%
CorVel Corp
AMLX4.050.09
+2.27%
Amylyx Pharmaceuticals
GPN112.031.45
+1.31%
Global Payments
SOND3.210.03
+0.94%
Sonder Holdings
ALEX17.47-0.06
-0.37%
Alexander & Baldwin